“We are also trying to deliver our export contracts but will make the domestic market a priority, all the requests coming from hospitals, pharmacies throughout the country. Our sales are on the rise, demand is 30% higher for all types of drugs at this time compared with the previous months. I suppose they are trying to build small inventories in hospitals,” Ioan Nani told ZF.
The company has ramped up production to make sure the stocks of drugs are sufficient for the next few months after production shuts down due to the COVID-19 pandemic.
“With more than 1,400 employees, we must adequately manage their health, so we moved to our second scenario, where we focus on production sites, distribution and online sales so as to be ale to ensure stocks for the next three to four months over the coming period, in the next two weeks at least, without any safety and continuity problems.”
The company has three scenarios it will use depending on the trend of the number of coronavirus cases and the steps taken by the authorities and is now working under the second scenario. The third, the crisis scenario, entails shutting down production and will be implemented one week before Easter, Ioan Nani says.
The drugs Antibiotice makes cannot be used directly to treat COVID-19 but only for additional treatment. Ioan Nani says that in case of pandemics, conflicts or natural disasters, some of the certified national producers must be able to make products that go from vaccines to drugs and other medical supplies.
(English version by Loredana Fratila-Cristescu)